Study on preoperative adjuvant therapy for rectal cancer

ZHU Xianggao,TIAN Jia,CHEN Yalin
DOI: https://doi.org/10.3969/j.issn.1006-5709.2009.06.006
2009-01-01
Abstract:Neoadjuvant chemoradiotherapy has been applied as standard treatment for stageⅡ and Ⅲ rectal cancer,which has better local control rate,sphincter preservation rate,survival rate,quality of life and lower toxicity comparing with postoperative chemoradiotherapy.With more and more application of chemotherapeutic agents and new compatibility regimen,individualized preoperative chemoradiotherapy will further improve therapeutic efficacy of rectal cancer.This article reviewed current status and development of preoperative radiochemotherapy for rectal cancer.
What problem does this paper attempt to address?